CION Investment Corporation 7.50% Notes due 2031 (CICC)
Live price chart, market sentiment, and community perspectives for CION Investment Corporation 7.50% Notes due 2031 (NYSE: CICC).
Live price chart, market sentiment, and community perspectives for CION Investment Corporation 7.50% Notes due 2031 (NYSE: CICC).
On our desk, the retail nature of CICC baby bonds means many buyers are chasing the 7.50% coupon without auditing CION's underlying portfolio schedule of investments. While the yield looks enticing just under 8% at a discount to par, we are carefully weighing the structural subordination behind $400 million in secured subsidiary borrowings before committing significant capital.
Watching the latest Q2 2026 reports, CION's net investment income of $0.29 per share failed to fully cover the $0.30 per share dividend even after a cut. This makes the common stock an easy pass for our team, but the fixed-income layer presents an intriguing profile if management follows through on its stated target to retire $270 million in total debt to improve asset coverage.
When evaluating the credit profile of CICC notes for our portfolio models, I note that non-accruals have dropped to a more manageable 1.44% of fair value alongside a rising NAV per share of $13.57. However, analysts must closely monitor whether management's private placements and debt paydown strategies translate into meaningful credit enhancement for senior unsecured holders.
Our risk management group flags that CION's leverage is currently hovering near regulatory minimums. While the company generated $16.8 million in net realized and unrealized gains leading to a 3.5% NAV bump this quarter, the execution risk of the broader deleveraging plan remains the primary variable for unsecured note holders.
From a market sentiment perspective, retail investors love the $25 exchange-listed denomination of CICC. The recent private placement of additional senior notes with equity floors and 150 percent asset-coverage minimum covenants shows management is actively trying to shore up institutional confidence while terming out obligations.
Explore plasma cleansing, somatic organ swaps, and BCI.